The global soft tissue sarcoma market has gained significant importance owing to advancements in cancer treatment, rising awareness about rare cancers, and increasing attention to early diagnosis. Valued at USD 3321.6 million in 2024 , the market is projected to reach USD 5343 million by 2032 , registering a compound annual...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά